Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPI-MINN: Targeting Cognition and Motivation in Coordinated Specialty Care for Early Psychosis: A National Comparison Study

NCT05877716 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05877716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05877716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPI-MINN: Targeting Cognition and Motivation in Coordinated Specialty Care for Early Psychosis: A National Comparison Study
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 30, 2023
Completion date
March 31, 2027
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depression with psychotic features, prodromal schizophrenia, psychosis, psychosis nos/other, schizo affective disorder, schizoaffective disorder, schizophrenia, schizophrenia spectrum and other psychotic disorders, schizophreniform disorders, unspecified psychosis